The future is biopharmaceutical. Research shows us that there are many active compounds which have already been isolated from cannabinoids with the potential to develop therapies effective in pain management and cancer treatment, to epilepsy and a variety of neural disorders. And that is only scratching the surface.
We are Scientus Pharma – a next gen R&D biopharmaceutical company based in Toronto and uniquely prepared to tap the revolutionary potential of this dynamic new medical frontier.
